-
Fungal IAA Drives Ferroptotic Conidial Death
2026-09-09
This study identifies fungus-derived indole-3-acetic acid (IAA) as a regulator of developmental conidial death in Magnaporthe oryzae. By connecting IAA biosynthesis, phosphatidylethanolamine metabolism, lipid peroxidation, autophagy, appressorium formation, and pathogenicity, the work defines a potential biochemical entry point for rice blast control.
-
Naftifine HCl: Assay Design Beyond the Label
2026-09-08
Naftifine HCl is an allylamine antifungal agent best understood through assay architecture, sterol-biosynthesis readouts, and rigorous controls. This article connects fungal mechanism research with lessons from a WNT5a/GSK3/β-catenin study while clearly defining the limits of cross-domain interpretation.
-
SLU-PP-332: Translating ERR Agonism
2026-09-08
SLU-PP-332 offers a research framework for connecting ERRα, ERRβ, and ERRγ activation with mitochondrial biology, cellular respiration, and metabolic translation. This thought-leadership analysis interprets the available skeletal-muscle evidence, outlines practical assay strategy, and defines the validation steps needed before exercise-mimetic or metabolic claims can move toward clinical relevance.
-
Trilaurin (Glycerol Tridodecanoate) Guide
2026-09-07
Trilaurin, also called Glycerol Tridodecanoate, is a defined C12 triacylglycerol used as a lipid excipient, biocatalytic synthesis substrate, and research material. In vitro evidence shows that trilaurin digestion can change desmopressin release and protect the peptide from proteolytic degradation under specific assay conditions.
-
CTP Solution for High-Fidelity p21 mRNA Workflows
2026-09-05
CTP Solution (100 mM) provides a concentrated, nuclease-controlled cytidine triphosphate source for in vitro transcription, RNA amplification, and pathway assays. This article connects reagent handling and reaction design to the localized p21 mRNA–LNP workflow reported for bladder cancer research, while separating product-supported facts from practical optimization recommendations.
-
Nitrendipine Sensitizes Colorectal Cancer to Oxaliplatin
2026-09-05
The reference study identifies nitrendipine, a clinically used dihydropyridine calcium-channel blocker, as a potential oxaliplatin chemosensitizer in colorectal cancer. Through functional assays, combination analysis, animal models, and CACNA1D-focused rescue experiments, it links the treatment effect to suppression of CACNA1D expression while also defining important preclinical limitations.
-
SM-102 for Localized mRNA Delivery Workflows
2026-09-04
SM-102 is an ionizable lipid building block for LNP-based mRNA delivery, with practical value in vaccine research and emerging localized therapeutic models. This guide translates its solvent, storage, formulation, and assay considerations into a reproducible workflow while distinguishing established findings from development-stage recommendations.
-
Spirocyclic POM Analogues Target MmpL3 in TB
2026-09-04
A 2024 Bioorganic Chemistry study developed spirocyclic phenyl oxazole methyl analogues and identified compound 5c as a potent inhibitor of Mycobacterium tuberculosis, including drug-resistant clinical isolates. Phenotypic screening, spontaneous mutant generation, docking, ADME, pharmacokinetic, and cytotoxicity studies together provide a useful framework for advancing MmpL3-directed antitubercular chemistry.
-
Triamcinolone: Research Workflow Guide
2026-09-03
Triamcinolone (B1859) is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses preparation, storage, assay controls, and troubleshooting; the compound is for scientific research only and is not intended for diagnostic, therapeutic, or clinical use.
-
Phosphotungstic Acid Negative Stain Solution Guide
2026-09-03
Convert fragile particles, glycoprotein complexes, and microbial specimens into high-contrast electron microscopy targets with a practical negative-staining workflow. This guide connects coronavirus spike-glycan research with actionable sample preparation, comparative imaging choices, and troubleshooting for reproducible virus imaging.
-
THZ1 Workflow for Covalent CDK7 Inhibition
2026-09-02
THZ1 is a covalent CDK7 inhibitor for time-resolved transcription studies, T-cell acute lymphoblastic leukemia (T-ALL) research, and cancer-cell response profiling. Its irreversible mechanism supports pulse-washout experiments that can distinguish early transcriptional shutdown from later proliferation loss or apoptosis.
-
CFDA SE Cell Tracer Kit: Technical Workflow
2026-09-02
The CFDA SE Cell Tracer Kit (SKU K1023) provides covalent fluorescent labeling for monitoring cell proliferation, cell lineage tracing, and longer-term cell recovery workflows. It is appropriate for stable in vitro or in vivo tracking, but not for reversible labeling, short-lived stains, or unvalidated real-time physiological measurements.
-
Brefeldin A: Reliable Cell Assay Workflows
2026-09-01
This scenario-driven guide explains how Brefeldin A (SKU B1400) can clarify viability, apoptosis, trafficking, and migration results when assay endpoints disagree. It combines product-based handling parameters with a cited endothelial-injury study to support better controls, interpretation, and vendor selection.
-
Hoechst 33342 for TNT Transport Imaging
2026-09-01
Hoechst 33342 adds a fast, live-cell nuclear reference to advanced tunneling nanotube transport experiments without replacing cargo-specific or force-sensitive readouts. This workflow shows how to combine nuclear segmentation, chromatin morphology, and cell-state controls with lipid-droplet tracking and optical trapping.
-
Dabigatran: From Thrombin Mechanism to Translation
2026-08-31
Dabigatran and Pradaxa provide a precise framework for studying thrombin-driven coagulation. This thought-leadership guide connects direct thrombin inhibition with catalpol’s broader cardio-cerebrovascular biology, offering translational researchers practical assay strategy, metabolite-aware interpretation, and a disciplined path from in vitro findings to clinically relevant questions.